UK markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
487.000.00 (0.00%)
At close: 04:00PM EST
486.50 -0.50 (-0.10%)
After hours: 05:57PM EST

IDEXX Laboratories, Inc.

One IDEXX Drive
Westbrook, ME 04092
United States
207 556 0300

IndustryDiagnostics & Research
Full-time employees10,000

Key executives

NameTitlePayExercisedYear born
Mr. Jonathan J. MazelskyPres, CEO & Director3.07M12.86M1961
Mr. Brian P. McKeonExec. VP & CFO1.43M26.11M1962
Mr. James F. PolewaczykExec. VP & Chief Commercial Officer1.19M5.61M1964
Mr. Michael J. LaneExec. VP and GM of Reference Laboratories & Information Technology1.19M4.05M1968
Dr. Nimrata Khatra Hunt P.E., Ph.D.Exec. VP of Strategy, Sector Devel. & Global Operations1.18M946.84k1969
Mr. John HartSr. VP of Global OperationsN/AN/AN/A
Mr. Jeffery D. ChadbourneSr. Director of Accounting & Financial ReportingN/AN/A1976
Dr. Martin Smith Ph.D.Exec. VP & CTON/AN/A1968
Mr. Ken GradySr. VP & Chief Information OfficerN/AN/AN/A
Ms. Sharon E. UnderbergExec. VP, Gen. Counsel, & Corp. Sec.N/AN/A1961
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Corporate governance

IDEXX Laboratories, Inc.’s ISS governance QualityScore as of 28 January 2023 is 5. The pillar scores are Audit: 7; Board: 1; Shareholder rights: 9; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.